Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2023  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

Year : 2006  |  Volume : 51  |  Issue : 3  |  Page : 222
Rifampicin induced thrombocytopenia

Dept. of Dermatology, NRS Medical College, Kolkata, India

Correspondence Address:
Sudip Das
Dept. of Dermatology, NRS Medical College, Kolkata
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5154.27995

Rights and Permissions

How to cite this article:
Das S, Roy A, Maiti A. Rifampicin induced thrombocytopenia. Indian J Dermatol 2006;51:222

How to cite this URL:
Das S, Roy A, Maiti A. Rifampicin induced thrombocytopenia. Indian J Dermatol [serial online] 2006 [cited 2023 Mar 23];51:222. Available from:

In the era of fixed drug therapy for Hansen MB-MDT, WHO recommends once monthly supervised dosage of rifampicin, 100 mg of unsupervised dapsone and clofazimine 50 mg unsupervised daily and 300 mg of supervised dosage of clofazimine (on 1st day of the month) for 1 year period. Normally these are administered even by the health assistant (male and female) in remote rural set up.

Adverse reactions to dapsone without any significant side effects include 'Dapsone syndrome', a rare potentially fatal infectious mononucleosis like condition and three kinds of haemolytic anaemia, almost universally from a direct membrane defect, uncommonly from glucose 6-phosphate dehydrogenase enzyme deficiency and rarely as an idiosyncratic response.[1]

The common serious problem with rifampicin is hepatotoxicity. Red urine is alarming but banal. Once monthly dose is very rarely associated with severe haemolysis and renal failure.

Association of thrombocytopenia and rifampicin has not been well described. We report a 40-year-old fruit vendor with multiple anesthetic plaques who was put on WHO MB-MDT (multi drug therapy). After two months of MB-MDT he developed multiple ecchymoses with bleeding from gum. Investigation revealed haemoglobin was 9.2 gm/dl, TLC-10,500/cmm. platelet count 17,000/cmm with normal bleeding and clotting time. On stoppage of ALT, parameters normalized in 2 to 3 weeks time. After we stopped ALT, we stopped the dapsone and put him on rifampicin and clofazimine, but within 24 hours he developed malaise, fatigue with purpuric spots and ecchymoses all over body. Although other haematologic parameters were normal, platelet count become 10000/cmm. We immediately stopped rifampicin and put the patient on minocycline along with clofazimine and dapsone. Platelet count improved in 3 weeks time and ecchymoses and purpura resolved by 1 week time.

The patient has now completed full treatment for one year, two months and is released from treatment.

Thrombocytopenia to rifampicin is described rarely in literature[2] and this report is aimed to make us cautious of the fact that even a single monthly supervised dose of rifampicin can cause thrombocytopenia, probably because of idiosyncratic reaction.

   References Top

1.Dhople AM. Search for newer anti Leprosy drugs. Indian J Leprosy 2000;72:19.  Back to cited text no. 1  [PUBMED]    
2.Depasquale G. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy. Lepr Rev 1986;46:29-37.  Back to cited text no. 2      

This article has been cited by
1 30 Drugs used in tuberculosis and leprosy
Banu Rekha, V.V., Swaminathan, S.
Side Effects of Drugs Annual. 2008; 30: 357-363


Print this article  Email this article
   Next article
   Previous article 
   Table of Contents
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (435 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


 Article Access Statistics
    PDF Downloaded138    
    Comments [Add]    
    Cited by others 1    

Recommend this journal